raloxifene hydrochloride has been researched along with Genetic Predisposition in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, C; House, M; Nichols, HB; Sandler, DP | 1 |
| Cohen, PR | 1 |
| Carlson, EE; Couch, FJ; Goetz, MP; Ingle, JN; Kubo, M; Mushiroda, T; Nakamura, Y; Paik, S; Schaid, DJ; Vachon, CM; Wang, L; Weinshilboum, R; Wickerham, DL; Wolmark, N | 1 |
| Callet, N; Fourme, E; Noguès, C; Reyal, F; Sénéchal, C; Stoppa-Lyonnet, D; This, P | 1 |
| Vogel, VG | 1 |
| Kolesar, JM; Simondsen, K; Zhang, Y | 1 |
| Blackwood, A; Calzone, K; Domchek, SM; Eisen, A; Stopfer, J; Weber, BL | 1 |
| Col, NF; Matloff, ET; Moyer, A; Shannon, KM | 1 |
| Rubinstein, WS | 1 |
| Carolin, KA; Pass, HA | 1 |
| Aba, F; Beckmann, MW; Bender, HG; Jap, D; Kuschel, B; Lux, M | 1 |
| Feigelson, HS; Henderson, BE | 1 |
| Fentiman, IS; Salih, AK | 1 |
8 review(s) available for raloxifene hydrochloride and Genetic Predisposition
| Article | Year |
|---|---|
[Hormonotherapy for breast cancer prevention: What about women with genetic predisposition to breast cancer?].
Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Endometrial Neoplasms; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Humans; Mastectomy; Mutation; Nitriles; Prophylactic Surgical Procedures; Raloxifene Hydrochloride; Tamoxifen; Triazoles | 2016 |
Preventing breast cancer in high-risk women, 2008.
Topics: Algorithms; Anticarcinogenic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Genetic Predisposition to Disease; Humans; Practice Guidelines as Topic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2008 |
Application of breast cancer risk prediction models in clinical practice.
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Models, Biological; Predictive Value of Tests; Raloxifene Hydrochloride; Risk Assessment; Tamoxifen | 2003 |
Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemoprevention; Drug Delivery Systems; Gene Expression Profiling; Genes, BRCA1; Genes, BRCA2; Genetic Carrier Screening; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Prognosis; Raloxifene Hydrochloride; Tamoxifen | 2008 |
Prevention of breast cancer.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Biological Products; Breast Neoplasms; Breast Neoplasms, Male; Carotenoids; Cathepsin D; Cell Adhesion Molecules; Cell Cycle; Clinical Trials, Phase III as Topic; Drug Screening Assays, Antitumor; Estrogens, Non-Steroidal; Female; Fenretinide; Genetic Predisposition to Disease; Hormone Antagonists; Humans; Isoflavones; Male; Mammary Neoplasms, Experimental; Mastectomy; Mice; Middle Aged; Neovascularization, Pathologic; Ovariectomy; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Rats; Retinoids; Risk Assessment; Risk Factors; Selenium; Tamoxifen; Terpenes | 2000 |
[Breast cancer: assessment of individual risk and possibilities for prevention].
Topics: Anticarcinogenic Agents; Breast Neoplasms; Female; Genetic Carrier Screening; Genetic Predisposition to Disease; Humans; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Tamoxifen | 2000 |
Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention.
Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Aromatase; Breast Neoplasms; Case-Control Studies; Estradiol Dehydrogenases; Estrogen Receptor alpha; Estrogens; Ethnicity; Female; Forecasting; Genetic Predisposition to Disease; Genetic Testing; Humans; Middle Aged; Models, Genetic; Ovary; Polymorphism, Genetic; Raloxifene Hydrochloride; Receptors, Estrogen; Reproductive History; Risk Factors; Selective Estrogen Receptor Modulators; Steroid 17-alpha-Hydroxylase; Tamoxifen | 2000 |
Breast cancer prevention: present and future.
Topics: Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Female; Genetic Predisposition to Disease; Humans; Neoplasms, Hormone-Dependent; Raloxifene Hydrochloride; Risk Factors; Tamoxifen | 2001 |
6 other study(ies) available for raloxifene hydrochloride and Genetic Predisposition
| Article | Year |
|---|---|
Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Estrogen Antagonists; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Prognosis; Prospective Studies; Raloxifene Hydrochloride; Risk Assessment; Tamoxifen | 2019 |
Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.
Topics: Administration, Topical; Anastrozole; Androstadienes; Aromatase Inhibitors; Estrogens; Female; Genetic Predisposition to Disease; Humans; Hyperpigmentation; Letrozole; Male; Melanosis; Neovascularization, Pathologic; Nitriles; Pregnancy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; Ultraviolet Rays; Vascular Endothelial Growth Factor A | 2017 |
Lowering your breast cancer risk. A daily pill can hold the key to prevention for some women.
Topics: Adult; Breast Neoplasms; Female; Genetic Predisposition to Disease; Humans; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Tamoxifen | 2014 |
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Prognosis; Raloxifene Hydrochloride; Receptors, Estrogen; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen | 2015 |
Exemestane for primary prevention of breast cancer in postmenopausal women.
Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemoprevention; Estrogen Antagonists; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Postmenopause; Primary Prevention; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen | 2012 |
Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling.
Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Decision Making; Endometrial Neoplasms; Estrogen Antagonists; Female; Genetic Counseling; Genetic Predisposition to Disease; Health Knowledge, Attitudes, Practice; Health Status; Humans; Menopause; Middle Aged; Models, Biological; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Tamoxifen | 2007 |